108 related articles for article (PubMed ID: 19415992)
1. Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients?
Schneider AB; Viana MA; Ron E
Thyroid; 2009 May; 19(5):435-6. PubMed ID: 19415992
[No Abstract] [Full Text] [Related]
2. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary breast cancer after radioactive iodine treatment in thyroid cancer: a systematic review and meta-analysis.
Zhang Y; Liang J; Li H; Cong H; Lin Y
Nucl Med Commun; 2016 Feb; 37(2):110-5. PubMed ID: 26513055
[TBL] [Abstract][Full Text] [Related]
4. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
de Vathaire F
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
[No Abstract] [Full Text] [Related]
5. Acute leukemias after treatment with radioiodine for thyroid cancer.
Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
[TBL] [Abstract][Full Text] [Related]
6. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
[TBL] [Abstract][Full Text] [Related]
7. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627
[TBL] [Abstract][Full Text] [Related]
8. Re: Cancer risk after iodine-131 therapy for hyperthyroidism.
Meyer MA
J Natl Cancer Inst; 1994 Jul; 86(13):1026-7. PubMed ID: 8007013
[No Abstract] [Full Text] [Related]
9. Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
Mei X; Yao X; Feng F; Cheng W; Wang H
BMC Cancer; 2021 May; 21(1):543. PubMed ID: 33980182
[TBL] [Abstract][Full Text] [Related]
10. Acute promyelocytic leukaemia following radioiodine therapy.
Richards EM; Marcus RE
Clin Lab Haematol; 1993; 15(1):55-8. PubMed ID: 8472497
[No Abstract] [Full Text] [Related]
11. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Dottorini ME; Lomuscio G; Mazzucchelli L; Vignati A; Colombo L
J Nucl Med; 1995 Jan; 36(1):21-7. PubMed ID: 7799075
[TBL] [Abstract][Full Text] [Related]
12. Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment.
Fallahi B; Adabi K; Majidi M; Fard-Esfahani A; Heshmat R; Larijani B; Haghpanah V
Clin Nucl Med; 2011 Apr; 36(4):277-82. PubMed ID: 21368600
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.
Yu CY; Saeed O; Goldberg AS; Farooq S; Fazelzad R; Goldstein DP; Tsang RW; Brierley JD; Ezzat S; Thabane L; Goldsmith CH; Sawka AM
Thyroid; 2018 Dec; 28(12):1662-1673. PubMed ID: 30370820
[No Abstract] [Full Text] [Related]
14. Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management.
Kumagai A; Reiners C; Drozd V; Yamashita S
Endocr J; 2007 Dec; 54(6):839-47. PubMed ID: 17938505
[TBL] [Abstract][Full Text] [Related]
15. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Glanzmann C
Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Reinecke MJ; Ahlers G; Burchert A; Eilsberger F; Flux GD; Marlowe RJ; Mueller HH; Reiners C; Rohde F; van Santen HM; Luster M
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3247-3256. PubMed ID: 35320386
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
[TBL] [Abstract][Full Text] [Related]
18. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
Seo GH; Cho YY; Chung JH; Kim SW
Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
[TBL] [Abstract][Full Text] [Related]
19. [Low risk of cancer after treatment of hyperthyroidism with iodine-131].
Holm LE; Hall P; Lundell G; Berg G; Bjelkengren G; Ericsson UB; Tennvall J; Hallquist A; Lidberg M; Wiklund K
Lakartidningen; 1992 Sep; 89(38):3043-6. PubMed ID: 1369747
[No Abstract] [Full Text] [Related]
20. Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer.
Piccirillo N; Sorà F; Laurenti L; Sica S; Chiusolo P; Leone G
Haematologica; 1999 Nov; 84(11):1050-1. PubMed ID: 10553170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
